
The University of Glasgow and Eli Lilly and Company have entered into a research collaboration, across four diseases, worth £4.6 …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

